ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney

Clinical Transplantation, Supplement

Volumn 18, Issue 12, 2004, Pages 55-60

  Bryan, Christopher F ^a   Cherikh, Wida S ^b   Cheng, Yulin ^b   Aeder, Mark I ^c   Muruve, Nicolas A ^d   Nelson, Paul W ^e   Shield III, Charles F ^f   Warady, Bradley A ^g   Winklhofer, Franz T ^h  

^a Midwest Transplant Network   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c Research Medical Center Brookside Campus   (United States)

^d University Hospital   (United States)

^e ST LUKE S HOSPITAL   (United States)

^f Via Christi Rehabilitation Center   (United States)

^g CHILDREN S MERCY HOSPITAL   (United States)

^h UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

A2; ABO; Allocation; B; HLA matched; Kidney; National; Policy; Zero mismatches

Indexed keywords

AGGLUTININ; HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; CHILD; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 4544237661     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00219.x     Document Type: Article

References (16)

1. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000: 343: 1078.
2. Hata Y, Cecka JM, Takemoto S, Ozawa M, Cho YW, Terasaki PI. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation 1998: 65: 208.
3. Stegall MD, Dean PG, McBride MA, Wynn JJ. Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation 2002: 74: 670.
4. Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000: 343: 1545.
5. Wallace ME, Gibbs FL, eds. Blood Group Systems: ABH and Lewis. Arlington, VA: American Association of Blood Banks, 1986.
6. Garratty G, Glynn S, McEntire R. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the USA. Transfusion 2001: 41 (Suppl.):107s.
7. Nelson PW, Hughes TM, Beck ML et al. Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O) transplantation by A-isoagglutinin-titer phenogroup. Transplant Proc 1996: 28: 221.
8. 2 kidneys: Time for a new national system? Am J Transplantation 2002: 2: 94.
9. Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF. Current experience with renal transplantation across the ABO barrier. Am J Surg 1992: 164: 541.
10. 2 kidneys. Transplantation 1999: 67: 1319.
11. 2 kidneys from living donors into group O and B recipients. Am J Transplantation 2001: 1: 296.
12. 2 donors. Transplant Proc 1991: 23: 1738.
13. 2 kidneys into O or B recipients: The effect of pretransplant anti-A titers on graft survival. Transplant Proc 1987: XIX: 4565.
14. Heiney DA. Public Comment Notice. Department within the organization, United Network for Organ Sharing, 2001. Richmond, VA.
15. Bariety J, Oriol R, Hinglais N et al. Distribution of blood group antigen A in normal and pathologic human kidneys. Kidney Int 1980: 17: 820.
16. Berneman ZN, van Bockstacle DR, Uyttenbroeck WM et al. Flow-cytometric analysis of erythrocytic blood group A antigen density profile. Vox Sang 1991: 61: 265.